Parting the Clouds over Typhoid with a New Conjugate Vaccine

Affiliations

Editorial

Florian Marks et al. N Engl J Med. 2019.

. 2019 Dec 5;381(23):2262-2264.

doi: 10.1056/NEJMe1914695.

¹ From the International Vaccine Institute, Seoul, South Korea (F.M., J.H.K.); and the University of Cambridge, Cambridge, United Kingdom (F.M.).

No abstract available

Comment on

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ; TyVAC Nepal Study Team. Shakya M, et al. N Engl J Med. 2019 Dec 5;381(23):2209-2218. doi: 10.1056/NEJMoa1905047. N Engl J Med. 2019. PMID: 31800986 Free PMC article. Clinical Trial.